Cargando…
Development of antiviral therapy for severe acute respiratory syndrome
A new disease, the severe acute respiratory distress syndrome (SARS), caused by the SARS coronavirus (SARS-CoV), emerged at the beginning of 2003 and rapidly spread throughout the world. Although the disease had disappeared in June 2003 its re-emergence cannot be excluded. The development of vaccine...
Autores principales: | Cinatl, Jindrich, Michaelis, Martin, Hoever, Gerold, Preiser, Wolfgang, Doerr, Hans Wilhelm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132397/ https://www.ncbi.nlm.nih.gov/pubmed/15878786 http://dx.doi.org/10.1016/j.antiviral.2005.03.002 |
Ejemplares similares
-
Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus
por: Cinatl Jr., J., et al.
Publicado: (2004) -
Investigation of the influence of EPs(®) 7630, a herbal drug preparation from Pelargonium sidoides, on replication of a broad panel of respiratory viruses
por: Michaelis, Martin, et al.
Publicado: (2011) -
Severe acute respiratory syndrome: identification of the etiological agent
por: Drosten, Christian, et al.
Publicado: (2003) -
Inhibition of apoptosis prevents West Nile virus induced cell death
por: Kleinschmidt, Malte C, et al.
Publicado: (2007) -
Glycyrrhizin Exerts Antioxidative Effects in H5N1 Influenza A Virus-Infected Cells and Inhibits Virus Replication and Pro-Inflammatory Gene Expression
por: Michaelis, Martin, et al.
Publicado: (2011)